These doses in subacute toxicity were selected from the effective dose (10 mg/kg) of Gαq-RGS2 signaling inhibitor against the cardiac arrhythmia in the rats in our previous study [6]. This evidence concerns the gene GNAQ and chronic obstructive pulmonary disease.